Literature DB >> 18829466

Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.

Sascha Jakob1, Peter Schroeder, Margarete Lukosz, Nicole Büchner, Ioakim Spyridopoulos, Joachim Altschmied, Judith Haendeler.   

Abstract

Aging is one major risk factor for numerous diseases. The enzyme telomerase reverse transcriptase (TERT) plays an important role for aging and apoptosis. Previously, we demonstrated that inhibition of oxidative stress-induced Src kinase family-dependent nuclear export of TERT results in delayed replicative senescence and reduced apoptosis sensitivity. Therefore, the aim of this study was to investigate mechanisms inhibiting nuclear export of TERT. First, we demonstrated that H2O2-induced nuclear export of TERT was abolished in Src, Fyn, and Yes-deficient embryonic fibroblasts. Next, we wanted to identify one potential negative regulator of this export process. One candidate is the protein tyrosine phosphatase Shp-2 (Shp-2), which can counteract activities of the Src kinase family. Indeed, Shp-2 was evenly distributed between the nucleus and cytosol. Nuclear Shp-2 associates with TERT in endothelial cells and dissociates from TERT prior to its nuclear export. Overexpression of Shp-2 wt inhibited H2O2-induced export of TERT. Overexpression of the catalytically inactive, dominant negative Shp-2 mutant (Shp-2(C459S)) reduced endogenous as well as overexpressed nuclear TERT protein and telomerase activity, whereas it had no influence on TERT(Y707F). Binding of TERT(Y707F) to Shp-2 is reduced compared with TERTwt. Ablation of Shp-2 expression led only to an increased tyrosine phosphorylation of TERTwt, but not of TERT(Y707F). Moreover, reduced Shp-2 expression decreased nuclear telomerase activity, whereas nuclear telomerase activity was increased in Shp-2-overexpressing endothelial cells. In conclusion, Shp-2 retains TERT in the nucleus by regulating tyrosine 707 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829466      PMCID: PMC2662250          DOI: 10.1074/jbc.M805138200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress.

Authors:  Shaheda Ahmed; João F Passos; Matthew J Birket; Tina Beckmann; Sebastian Brings; Heiko Peters; Mark A Birch-Machin; Thomas von Zglinicki; Gabriele Saretzki
Journal:  J Cell Sci       Date:  2008-03-11       Impact factor: 5.285

2.  Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation.

Authors:  Judith Haendeler; Jörg Hoffmann; Sandy Rahman; Andreas M Zeiher; Stefanie Dimmeler
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

3.  Aging-related attenuation of EGF receptor signaling is mediated in part by increased protein tyrosine phosphatase activity.

Authors:  Kien T Tran; S Diana Rusu; Latha Satish; Alan Wells
Journal:  Exp Cell Res       Date:  2003-10-01       Impact factor: 3.905

4.  ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation.

Authors:  Masaki Osawa; Seigo Itoh; Shinsuke Ohta; Qunhua Huang; Bradford C Berk; Nicole-Lerner Marmarosh; Wenyi Che; Bo Ding; Chen Yan; Jun-ichi Abe
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

5.  Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.

Authors:  Jian Feng Wang; Xuefeng Zhang; Jerome E Groopman
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

6.  Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells.

Authors:  Judith Haendeler; Jörg Hoffmann; J Florian Diehl; Mariuca Vasa; Ioakim Spyridopoulos; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

7.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling.

Authors:  K Yamauchi; K L Milarski; A R Saltiel; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin.

Authors:  K L Milarski; A R Saltiel
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

9.  Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.

Authors:  Naila Chughtai; Sarah Schimchowitsch; Jean-Jacques Lebrun; Suhad Ali
Journal:  J Biol Chem       Date:  2002-06-11       Impact factor: 5.157

10.  Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707.

Authors:  Judith Haendeler; Jörg Hoffmann; Ralf P Brandes; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more
  29 in total

Review 1.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

2.  SHP-2 tyrosine phosphatase in human diseases.

Authors:  Hong Zheng; Shawn Alter; Cheng-Kui Qu
Journal:  Int J Clin Exp Med       Date:  2009-01-30

3.  Nuclear Shp2 directs normal embryo implantation via facilitating the ERα tyrosine phosphorylation by the Src kinase.

Authors:  Hao Ran; Shuangbo Kong; Shuang Zhang; Jianghong Cheng; Chan Zhou; Bo He; Qiliang Xin; John P Lydon; Francesco J DeMayo; Gen-Sheng Feng; Guoliang Xia; Zhongxian Lu; Chao Wang; Haibin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-19       Impact factor: 11.205

4.  Impact of mitochondrial telomerase over-expression on drug resistance of hepatocellular carcinoma.

Authors:  Jing Yan; Yuan Zhou; Daixing Chen; Lili Li; Xin Yang; Yang You; Xianlong Ling
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

5.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

Review 6.  When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.

Authors:  Saumya R Bollam; Michael E Berens; Harshil D Dhruv
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-10       Impact factor: 5.081

7.  Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability.

Authors:  Xia Liu; Hong Zheng; Cheng-Kui Qu
Journal:  Cancer Res       Date:  2012-08-13       Impact factor: 12.701

8.  S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke.

Authors:  Zhong-Qing Shi; Carmen R Sunico; Scott R McKercher; Jiankun Cui; Gen-Sheng Feng; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  "Shping 2" different cellular localizations - a potential new player in aging processes.

Authors:  Sascha Jakob; Joachim Altschmied; Judith Haendeler
Journal:  Aging (Albany NY)       Date:  2009-06-29       Impact factor: 5.682

10.  New approaches to prevent LEOPARD syndrome-associated cardiac hypertrophy by specifically targeting Shp2-dependent signaling.

Authors:  Christine Schramm; Michelle A Edwards; Maike Krenz
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.